Menu Back to Benefit-Risk-Assessment-from-Inception-to-Maturation-Aligning-Regulatory-and-Industry-Goals

Program Committee

  • K. Kimberly  McCleary
    K. Kimberly McCleary Managing Director
    FasterCures, A Center of the Milken Institute, United States
  • Rebecca A. Noel
    Rebecca A. Noel Global Benefit-Risk Lead, Global Patient Safety
    Eli Lilly and Company, United States
  • Bennett  Levitan, MD, PhD
    Bennett Levitan, MD, PhD Senior Director, Benefit-Risk Assessment, Department of Epidemiology
    Janssen Research & Development, LLC, United States
  • Marilyn A. Metcalf, PhD
    Marilyn A. Metcalf, PhD Head, Center of Innovation
    GlaxoSmithKline, United States
  • Lawrence Eugene Liberti, MS, RPh, RAC
    Lawrence Eugene Liberti, MS, RPh, RAC Executive Director
    Centre for Innovation in Regulatory Science (CIRS), United States
Load More

Digital Learning Catalog

eLearning Catalog Cover